Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 1/2006

01-11-2006 | Case Report

A case of hepatocellular carcinoma who admitted with Raynaud’s phenomenon

Authors: Cem Sahan, Tanja Ucer, Emre Aksakal

Published in: Rheumatology International | Issue 1/2006

Login to get access

Abstract

Hepatocellular carcinoma (HCC) may be present in one of the several ways. The classical presentation is with right upper quadrant abdominal pain, abdominal swelling and weight loss. HCC may also be associated with several paraneoplastic manifestations. The mechanisms of these manifestations are not well known. The association of digital ischemia and malignancy was reported as early as 1884 and 1891. We report a case of HCC associated with Raynaund’s phenomenon.
Literature
1.
O’Connor B (1884) Symmetrical gangrene. Br Med J 1:460
2.
Pagge CH, Pye-Smith PH. Textbook of principles and practice of medicine, vol 2, 3rd edn. London J&A Churchill, 1891:118
3.
Bisceglie AM (1999) Malignant neoplasm of the liver. In: Schiff ER, Sorreil MF, Maddrey WC (eds.). Schifl disease of the liver, vol 2. 8th edn. Lippincott Williams and Wilkins, Philadelphia, pp 1281–1304
4.
Pasteur W, Price-Jones C (1901) A case of cancer of stomach, with unusual vascular and blood changes. Trans Clin Soc Lond 34:160–164
5.
Hamilton WF (1920) Carcinoma of oesophagus and Raynaud’s disease. Can Med Assoc J 1:670–671
6.
Bennet Tl, Poulton EP (1928) Raynaud’s disease associated with cancer of the stomach. Am J Med Sci 176:654–657CrossRef
7.
Domz CA, Chapman CG (1961) Pseudo-Raynaud’s; cryoglobulinemia secondary to occult neoplasm. Calif Med 95:391–393PubMed
8.
De Cross M (1992) Paraneoplastic Raynaud’s phenomenon. Am J Med 92:571–572CrossRef
9.
Prescott RJ, Fremaont AJ, Jones et al (1992) Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 166:255–263PubMedCrossRef
10.
Zignego AL, Brechot C (1999) Extrahepatic manifestations of HCV infection: facts and controversies. J Hepatol 31:369–376PubMedCrossRef
11.
Gorevic PD, Kassab HY, Levo Y et al (1980) Mixed cryoglobulinemia: clinical aspects and long term follow-up of 40 patients. Am J Med 287:69–75
12.
McMurray RW (1998) Hepatitis C associated autoimmune disorders. Rheum Dis Clin 24:353–374CrossRef
Metadata
Title
A case of hepatocellular carcinoma who admitted with Raynaud’s phenomenon
Authors
Cem Sahan
Tanja Ucer
Emre Aksakal
Publication date
01-11-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-006-0154-z

Other articles of this Issue 1/2006

Rheumatology International 1/2006 Go to the issue

Case Report

Intra-articular glucocorticoid injection: an unusual cause of transient hypophosphataemia

Original Article

Tumor necrosis factor receptor 2 M196R polymorphism in rheumatoid arthritis and osteoarthritis: relationship with sTNFR2 levels and clinical features

Original Article

Balneotherapy and tap water therapy in the treatment of knee osteoarthritis

Acknowlegedment to Referees

Acknowledgement to Referees

Original Article

Prevalence and correlates of inflammatory arthritis in Germany: data from the First National Health Survey

Original Article

Adenosine and cytokine levels following treatment of rheumatoid arthritis with dipyridamole
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits